Imaging company EMVision Medical Devices is preparing for a meeting with the US Food and Drug Administration as it edges closer to seeking approval to market its emu point of care scanner to detect stroke. The company has been developing a system that uses microwaves and AI in a machine small enough to fit in…
US technology company Keysight Technologies has taken a strategic stake worth $15.28 million in medical imaging company EMVision. In a statement on Thursday, EMVision said the investment represented a significant milestone, and would accelerate commercialisation of the portable brain scanner emu, its first product. Keysight will be issued 7,454,231 new ordinary shares at $2.05 per…
Medical imaging manufacturer EMVision Medical Devices is further developing its innovative portable brain scanner. The company’s first generation scanner, which uses microwave imaging techniques to detect strokes at the point of care, is undergoing clinical testing. Now the Brisbane company has assembled an advanced 28-antenna prototype of its 2nd generation ultra-light weight helmet scanner (pictured)…
Brain imaging technology company EMVision Medical Devices has announced promising clinical trial results from a patient study of its haemorrhagic stroke detection algorithm. The algorithm, dubbed ‘blood or not’, is a critical part of the microwave imaging system the company is developing under a grant from the Australian Stroke Alliance, to be fitted to point…
Brain imaging company EMVision Medical Devices has announced receipt of a $1.75 million payment under the Modern Manufacturing Initiative (MMI) grant. EMVision was awarded a grant worth $5 million in non-dilutive funding in May 2022 from the previous federal government’s MMI. The funding under the initiative’s Translation stream is to assist establishing commercial production of…
Brain imaging technology company EMVision Medical Devices has moved to its second phase of human testing of its innovative portable brain scanner. The company’s first generation scanner, which uses microwave imaging techniques to detect strokes at an early stage, previously successfully completed a stage 1 trial with 30 healthy volunteers. The scanner is aimed for…
Brain imaging technology company EMVision Medical Devices has given an update on progress of its clinical trial and a Medical Research Future Fund-backed R&D program, with the latter seeing the company access a $600,000 milestone payment. The clinical trials are in the pre-validation phase and running to schedule, according to a statement from EMVision on…
Medical device maker EMVision has been awarded $5 million in funding by the Department of Industry, Science and Resources to aid commercialisation of its portable brain scanner. EMVision was awarded the $5 million under the Modern Manufacturing Initiative grant award under the Medical products Manufacturing Translation steam to help establish commercial production of its 1st…
Brain imaging technology company EMVision has named Liverpool Hospital in NSW and Royal Melbourne Hospital in Victoria as the first two sites as part of a planned multi-site clinical trial this quarter.
Brain imaging company EMVision Medical Devices has successfully passed a milestone in its five-year project in partnership with the Australian Stroke Alliance, releasing $600,000 in funding to further development of its portable scanning device.
